194 related articles for article (PubMed ID: 37552884)
1. Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer.
Ordonez-Rubiano SC; Maschinot CA; Wang S; Sood S; Baracaldo-Lancheros LF; Strohmier BP; McQuade AJ; Smith BC; Dykhuizen EC
J Med Chem; 2023 Aug; 66(16):11250-11270. PubMed ID: 37552884
[TBL] [Abstract][Full Text] [Related]
2. Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains.
Clegg MA; Bamborough P; Chung CW; Craggs PD; Gordon L; Grandi P; Leveridge M; Lindon M; Liwicki GM; Michon AM; Molnar J; Rioja I; Soden PE; Theodoulou NH; Werner T; Tomkinson NCO; Prinjha RK; Humphreys PG
J Med Chem; 2020 Jun; 63(11):5816-5840. PubMed ID: 32410449
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.
Karim RM; Chan A; Zhu JY; Schönbrunn E
J Med Chem; 2020 Mar; 63(6):3227-3237. PubMed ID: 32091206
[TBL] [Abstract][Full Text] [Related]
4. NMR Fragment Screening Hit Induces Plasticity of BRD7/9 Bromodomains.
Wang N; Li F; Bao H; Li J; Wu J; Ruan K
Chembiochem; 2016 Aug; 17(15):1456-63. PubMed ID: 27194508
[TBL] [Abstract][Full Text] [Related]
5. Development of chemical probes for the bromodomains of BRD7 and BRD9.
Clark PG; Dixon DJ; Brennan PE
Drug Discov Today Technol; 2016 Mar; 19():73-80. PubMed ID: 27769361
[TBL] [Abstract][Full Text] [Related]
6. LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.
Clark PG; Vieira LC; Tallant C; Fedorov O; Singleton DC; Rogers CM; Monteiro OP; Bennett JM; Baronio R; Müller S; Daniels DL; Méndez J; Knapp S; Brennan PE; Dixon DJ
Angew Chem Int Ed Engl; 2015 May; 54(21):6217-21. PubMed ID: 25864491
[TBL] [Abstract][Full Text] [Related]
7. Biological function and histone recognition of family IV bromodomain-containing proteins.
Lloyd JT; Glass KC
J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
[TBL] [Abstract][Full Text] [Related]
8. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.
Sun H; Liu J; Zhang J; Shen W; Huang H; Xu C; Dai H; Wu J; Shi Y
Biochem Biophys Res Commun; 2007 Jun; 358(2):435-41. PubMed ID: 17498659
[TBL] [Abstract][Full Text] [Related]
10. Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations.
Su J; Liu X; Zhang S; Yan F; Zhang Q; Chen J
Chem Biol Drug Des; 2019 Feb; 93(2):163-176. PubMed ID: 30225973
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.
Peng C; Zhou J; Liu HY; Zhou M; Wang LL; Zhang QH; Yang YX; Xiong W; Shen SR; Li XL; Li GY
J Cell Biochem; 2006 Mar; 97(4):882-92. PubMed ID: 16265664
[TBL] [Abstract][Full Text] [Related]
12. Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations.
Wang L; Wang Y; Zhao J; Yu Y; Kang N; Yang Z
RSC Adv; 2022 Jun; 12(26):16663-16676. PubMed ID: 35754900
[TBL] [Abstract][Full Text] [Related]
13. 4-Acyl Pyrroles as Dual BET-BRD7/9 Bromodomain Inhibitors Address BETi Insensitive Human Cancer Cell Lines.
Hügle M; Regenass P; Warstat R; Hau M; Schmidtkunz K; Lucas X; Wohlwend D; Einsle O; Jung M; Breit B; Günther S
J Med Chem; 2020 Dec; 63(24):15603-15620. PubMed ID: 33275431
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of bromodomain ligands targeting BAZ2A.
Cazzanelli G; Vedove AD; Parolin E; D'Agostino VG; Unzue A; Nevado C; Caflisch A; Lolli G
Protein Sci; 2023 Sep; 32(9):e4752. PubMed ID: 37574751
[TBL] [Abstract][Full Text] [Related]
15. LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.
Clark PG; Vieira LC; Tallant C; Fedorov O; Singleton DC; Rogers CM; Monteiro OP; Bennett JM; Baronio R; Müller S; Daniels DL; Méndez J; Knapp S; Brennan PE; Dixon DJ
Angew Chem Weinheim Bergstr Ger; 2015 May; 127(21):6315-6319. PubMed ID: 27346896
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
[TBL] [Abstract][Full Text] [Related]
17. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Functional Interplay between the BRD7 and BRD9 Homologues in mSWI/SNF Complexes.
Agbo L; Loehr J; Kougnassoukou Tchara PE; Lambert JP
J Proteome Res; 2023 Jan; 22(1):78-90. PubMed ID: 36484504
[TBL] [Abstract][Full Text] [Related]
19. Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain.
Hudson BP; Martinez-Yamout MA; Dyson HJ; Wright PE
J Mol Biol; 2000 Dec; 304(3):355-70. PubMed ID: 11090279
[TBL] [Abstract][Full Text] [Related]
20. TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells.
Kikuchi M; Okumura F; Tsukiyama T; Watanabe M; Miyajima N; Tanaka J; Imamura M; Hatakeyama S
Biochim Biophys Acta; 2009 Dec; 1793(12):1828-36. PubMed ID: 19909775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]